Diabetes Mellitus
Conditions
Keywords
Trichosanthes root, Traditional Chinese Medicine, Clinical trial
Brief summary
Diabetes mellitus (DM) locates fifth of ten leading death etiology, the population of diabetic patients has a tendency of increase. Trichosanthes root is called as Tian Hua Fen, According to traditional Chinese writing record that Trichosanthes root has the action of downbear fire, moisten dryness, and slippery phlegm, and release thirst. The Trichosanthes root may lower blood sugar levels in the modern study. The investigators designed a double blind, randomized controlled study, a total of 60 diabetic patients with high blood sugar were divided into treatment and control groups, and each group was 30 patients. In the treatment group, oral administration of Trichosanthes root 1.5 g, bid/day for 84 days continuously; in the control group, oral administration of Trichosanthes root placebo 1.5 g, bid/day for 84 days continuously. The main outcome measure was the changes of plasma blood sugar and Glycated hemoglobin A1c (HbA1c) levels changed before and after Trichosanthes root treatment. The investigators predict the results of the present study indicated that Trichosanthes root can improve plasma blood sugar and glycated hemoglobin A1c levels.
Interventions
DRUGTrichosanthes root
Trichosanthes root at a rate of 1.5 g two times per day for 84 days.
DRUGPlacebo
Trichosanthes root at a rate of 0.15g (10%) two times per day for 84 days.
Sponsors
China Medical University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. Early diagnosis Type Ⅱ Diabetic patients who Glycated hemoglobin A1c level between 7.0% and 9.0% (including) , and after three months of diet and exercise control. 2. The subject who was taking hypoglycemic drugs Metformin, the maximum total amount of ≦ 1500 mg / day. 3. Age ranged between 20 and 80 years (including).
Exclusion criteria
1. Pregnancy or breast-finding. 2. Allergy to test medicine. 3. Type I Diabetic patients. 4. Bleeding tendency. 5. The participants who suffered from serious disorders, such as congestive heart failure, myocardial infarction, chronic obstructive pulmonary disease, renal failure, cancer or stroke etc. 6. Irritable or anxious patients who cannot be assessed. 7. Refuse to sign the agreement. 8. The values of SGOT and SGPT levels were more than normal limit triple, or the value of creatinine level was more than normal limit. 9. Plasm glucose(Glucose AC) level in fasting state ≧ 300 mg / dL.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Glycated hemoglobin A1c | Three months | Improvement of glycated hemoglobin A1c levels |
| Plasma Blood Sugar | Three months | Improvement of Plasma Blood Sugar levels |
Countries
Taiwan
Contacts
Primary ContactChing-Liang Hsieh, M.D., Ph.D
Outcome results
None listed